DOSSIER · 13F Holders · Q2 2026
MNLOUSD
VYNE THERAP.
2 institutions still hold VYNE THERAP. as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 92941V209·2 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
2 institutions reported MNLOUSD in Q2 2026. STALEY CAPITAL ADVISERS INC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.